A new immunotherapy, tested for the blood cancer acute lymphoblastic leukemia (ALL), demonstrated impressive results in early clinical trials, of among several dozen patients.
Read more at Drug Discovery & Development.
By R&D Editors |
A new immunotherapy, tested for the blood cancer acute lymphoblastic leukemia (ALL), demonstrated impressive results in early clinical trials, of among several dozen patients.
Read more at Drug Discovery & Development.